EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of PTCH1 drug efflux activity enhances chemotherapy efficacy against triple negative breast cancers

Sarah Cogoluegnes, Sandra Kovachka, Thierry Dubois, Roberto Würth, Elisa Donato, Andreas Trumpp, Michel Franco, Frédéric Luton, Stéphane Azoulay, Isabelle Mus-Veteau

Translational Oncology · 2026-06 · 68 · 102777

DOI: 10.1016/j.tranon.2026.102777 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2026-06. Verfasst von Sarah Cogoluegnes und 9 weiteren Autor:innen. Beteiligte Einrichtung: University Côte d'Azur, CNRS, INSERM, IPMC, 660 route des Lucioles, Valbonne 06560, France. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French National Research Agency, Université Clermont-Auvergne, Centre National de la Recherche Scientifique.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Chemotherapy resistanceDocetaxelDoxorubicinDrug effluxPTCH1TNBC

Autor:innen und Institutionen

  • University Côte d'Azur, CNRS, INSERM, IPMC, 660 route des Lucioles, Valbonne 06560, France.
  • University Côte d'Azur, CNRS, ICN, 28 Avenue Valrose, 06108, Nice CEDEX 2, France.
  • Institut Curie, PSL University, Sorbonne Université, Translational Research Department, CNRS UMR144 Cell Biology and Cancer, Breast Cancer Biology Group, 26 rue d'Ulm, Paris 75005, France.
  • Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg 69120, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelb…
  • University Côte d'Azur, CNRS, INSERM, IPMC, 660 route des Lucioles, Valbonne 06560, France. Electronic address: mus-veteau@ipmc.cnrs.fr.

Förderung

  • French National Research Agency
  • Université Clermont-Auvergne
  • Centre National de la Recherche Scientifique

Zitieren

APA

Cogoluegnes, S., Kovachka, S., Dubois, T., Würth, R., Donato, E., Trumpp, A., Franco, M., Luton, F., Azoulay, S., & Mus-Veteau, I. (2026). Inhibition of PTCH1 drug efflux activity enhances chemotherapy efficacy against triple negative breast cancers. Translational Oncology, 68, 102777. https://doi.org/10.1016/j.tranon.2026.102777

Vancouver

Cogoluegnes S, Kovachka S, Dubois T, Würth R, Donato E, Trumpp A, et al. Inhibition of PTCH1 drug efflux activity enhances chemotherapy efficacy against triple negative breast cancers. Translational Oncology. 2026;68:102777. doi:10.1016/j.tranon.2026.102777

BibTeX
@article{Cogoluegnes2026,
  author = {Cogoluegnes, Sarah and Kovachka, Sandra and Dubois, Thierry and Würth, Roberto and Donato, Elisa and Trumpp, Andreas and Franco, Michel and Luton, Frédéric and Azoulay, Stéphane and Mus-Veteau, Isabelle},
  title = {Inhibition of PTCH1 drug efflux activity enhances chemotherapy efficacy against triple negative breast cancers},
  journal = {Translational Oncology},
  year = {2026},
  volume = {68},
  pages = {102777},
  doi = {10.1016/j.tranon.2026.102777}
}
Kostenlos starten →